Initial IL-10 production dominates the therapy of mesenchymal stem cell scaffold in spinal cord injury.
Journal Information
Full Title: Theranostics
Abbreviation: Theranostics
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Diagnostic Imaging
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"all high-throughput data were deposited in the ncbi gene expression omnibus (geo) database under the accession number geo: gse240755."
"Competing Interests: The authors have declared that no competing interest exists."
"This work was supported by the National Natural Science Foundation of China (No. 82104181, 81973252, 81620108028), and the National Key Research and Development Project of Stem Cell and Transformation Research (No. 2019YFA0112100, 2019YFA0112102). We thank SinoCell Technology Co., Ltd. (Ningbo, China) for the human umbilical cord derived MSCs and technical support."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025